|Title||Healthcare Costs of Post-Prostate Biopsy Sepsis.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Gross MD, Alshak MN, Shoag JE, Laviana AA, Gorin MA, Sedrakyan A, Hu JC|
|Date Published||2019 Jun 21|
Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.
Division:Comparative Effectiveness & Outcomes Research